142 related articles for article (PubMed ID: 20173221)
1. [Onconase: a ribonuclease with antitumor activity].
Zwolińska M; Smolewski P
Postepy Hig Med Dosw (Online); 2010 Feb; 64():58-66. PubMed ID: 20173221
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Jurkat acute T-lymphocytic leukemia cells by onconase (Ranpirnase) is accompanied by an altered nucleocytoplasmic distribution and reduced expression of transcription factor NF-kappaB.
Tsai SY; Ardelt B; Hsieh TC; Darzynkiewicz Z; Shogen K; Wu JM
Int J Oncol; 2004 Dec; 25(6):1745-52. PubMed ID: 15547713
[TBL] [Abstract][Full Text] [Related]
3. Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes.
Ardelt W; Shogen K; Darzynkiewicz Z
Curr Pharm Biotechnol; 2008 Jun; 9(3):215-25. PubMed ID: 18673287
[TBL] [Abstract][Full Text] [Related]
4. Ranpirnase: amphibian ribonuclease A, P-30 protein-alfacell.
Drugs R D; 2007; 8(2):120-4. PubMed ID: 17324010
[TBL] [Abstract][Full Text] [Related]
5. Ranpirnase as a potential antitumor ribonuclease treatment for mesothelioma and other malignancies.
Beck AK; Pass HI; Carbone M; Yang H
Future Oncol; 2008 Jun; 4(3):341-9. PubMed ID: 18518759
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.
Rybak SM; Pearson JW; Fogler WE; Volker K; Spence SE; Newton DL; Mikulski SM; Ardelt W; Riggs CW; Kung HF; Longo DL
J Natl Cancer Inst; 1996 Jun; 88(11):747-53. PubMed ID: 8637029
[TBL] [Abstract][Full Text] [Related]
7. Ribonucleases as novel chemotherapeutics : the ranpirnase example.
Lee JE; Raines RT
BioDrugs; 2008; 22(1):53-8. PubMed ID: 18215091
[TBL] [Abstract][Full Text] [Related]
8. Ranpirnase (Onconase), a cytotoxic amphibian ribonuclease, manipulates tumour physiological parameters as a selective killer and a potential enhancer for chemotherapy and radiation in cancer therapy.
Lee I
Expert Opin Biol Ther; 2008 Jun; 8(6):813-27. PubMed ID: 18476793
[TBL] [Abstract][Full Text] [Related]
9. Ribonucleases as a novel pro-apoptotic anticancer strategy: review of the preclinical and clinical data for ranpirnase.
Costanzi J; Sidransky D; Navon A; Goldsweig H
Cancer Invest; 2005; 23(7):643-50. PubMed ID: 16305992
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of enhanced tumoricidal efficacy of multiple small dosages of ranpirnase, the novel cytotoxic ribonuclease, on lung cancer.
Lee I; Shogen K
Cancer Chemother Pharmacol; 2008 Jul; 62(2):337-46. PubMed ID: 18064463
[TBL] [Abstract][Full Text] [Related]
11. A Novel Ribonuclease from Rana Chensinensis and Its Potential for the Treatment of Human Breast Cancer.
Wang Z; Lin F; Liu J; Qiu F
Cancer Biother Radiopharm; 2015 Nov; 30(9):380-5. PubMed ID: 26502078
[TBL] [Abstract][Full Text] [Related]
12. Ribonucleases as potential modalities in anticancer therapy.
Ardelt W; Ardelt B; Darzynkiewicz Z
Eur J Pharmacol; 2009 Dec; 625(1-3):181-9. PubMed ID: 19825371
[TBL] [Abstract][Full Text] [Related]
13. Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.
Boix E; Wu Y; Vasandani VM; Saxena SK; Ardelt W; Ladner J; Youle RJ
J Mol Biol; 1996 Apr; 257(5):992-1007. PubMed ID: 8632481
[TBL] [Abstract][Full Text] [Related]
14. Cancer chemotherapy--ribonucleases to the rescue.
Leland PA; Raines RT
Chem Biol; 2001 May; 8(5):405-13. PubMed ID: 11358688
[TBL] [Abstract][Full Text] [Related]
15. Antibody-onconase conjugates: cytotoxicity and intracellular routing.
Rybak SM
Curr Pharm Biotechnol; 2008 Jun; 9(3):226-30. PubMed ID: 18673288
[TBL] [Abstract][Full Text] [Related]
16. Interferon enhances the activity of the anticancer ribonuclease, onconase.
Vasandani VM; Castelli JC; Hott JS; Saxena S; Mikulski SM; Youle RJ
J Interferon Cytokine Res; 1999 May; 19(5):447-54. PubMed ID: 10386856
[TBL] [Abstract][Full Text] [Related]
17. Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of Onconase.
Vert A; Castro J; Ribó M; Benito A; Vilanova M
Oncotarget; 2017 Feb; 8(7):11692-11707. PubMed ID: 28035074
[TBL] [Abstract][Full Text] [Related]
18. A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity.
Wu Y; Mikulski SM; Ardelt W; Rybak SM; Youle RJ
J Biol Chem; 1993 May; 268(14):10686-93. PubMed ID: 8486718
[TBL] [Abstract][Full Text] [Related]
19. The interdependence between catalytic activity, conformational stability, and cytotoxicity of onconase.
Schulenburg C; Ardelt B; Ardelt W; Arnold U; Shogen K; Ulbrich-Hofmann R; Darzynkiewicz Z
Cancer Biol Ther; 2007 Aug; 6(8):1233-9. PubMed ID: 17637563
[TBL] [Abstract][Full Text] [Related]
20. [Effective expression of ribonuclease-onconase in Escherichia coli and assaying its cytotoxic potential].
Xu GF; Wang QC; Gong XG; Fei J
Shi Yan Sheng Wu Xue Bao; 2004 Jun; 37(3):227-31. PubMed ID: 15323425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
